Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.
作者信息
Uy Geoffrey L, Newell Laura F, Lin Tara L, Goldberg Stuart L, Wieduwilt Matthew J, Ryan Robert J, Faderl Stefan, Lancet Jeffrey E
机构信息
Division of Oncology, Washington University School of Medicine, St. Louis, MO.
Knight Cancer Institute, Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR.
出版信息
Blood Adv. 2022 Sep 13;6(17):4989-4993. doi: 10.1182/bloodadvances.2021006468.
Abstract
摘要
Zotero 插件